Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches
Open Access
- 16 May 2022
- Vol. 11 (5), 757
- https://doi.org/10.3390/biology11050757
Abstract
Helicobacter pylori infection is the only well-established bacterial cause of cancer. However, due to the integral role of tissue-resident commensals in maintaining tissue-specific immunometabolic homeostasis, accumulated evidence suggests that an imbalance of tissue-resident microbiota that are otherwise considered as commensals, can also promote various types of cancers. Therefore, the present review discusses compelling evidence linking tissue-resident microbiota (especially gut bacteria) with cancer initiation and progression. Experimental evidence supporting the cancer-causing role of gut commensal through the modulation of host-specific processes (e.g., bile acid metabolism, hormonal effects) or by direct DNA damage and toxicity has been discussed. The opportunistic role of commensal through pathoadaptive mutation and overcoming colonization resistance is discussed, and how chronic inflammation triggered by microbiota could be an intermediate in cancer-causing infections has been discussed. Finally, we discuss microbiota-centric strategies, including fecal microbiota transplantation, proven to be beneficial in preventing and treating cancers. Collectively, this review provides a comprehensive understanding of the role of tissue-resident microbiota, their cancer-promoting potentials, and how beneficial bacteria can be used against cancers.Keywords
Funding Information
- Science and Engineering Research Board (SRG/2021/000082)
This publication has 303 references indexed in Scilit:
- TLR4 Activates the β-catenin Pathway to Cause Intestinal NeoplasiaPLOS ONE, 2013
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4Cancer Cell, 2012
- Microbiome and MalignancyCell Host & Microbe, 2011
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteersThe ISME Journal, 2011
- Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignanciesInternational Journal of Infectious Diseases, 2011
- Helicobacter pylori virulence factors in gastric carcinogenesisCancer Letters, 2009
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesNature Medicine, 2009
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006